InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Grissinger Michael. Insider active across 1 company, notably Aprea Therapeutics, Inc.. In total, 5 disclosures have been logged. History available since 28 July 2022. The latest transaction was disclosed on 5 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Grissinger Michael is a declarant and is listed as a director of Aprea Therapeutics, Inc. on XNAS. He has 5 filings in total, and the sampled recent filings cover the period from 2022-08-01 to 2026-06-17, with buy and sell amounts of 0, and a modal transaction nature indicated as Attribution.